↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

141 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 0.5 mg budesonide effervescent tablet for orodispersible use Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
2 1 mg budesonide effervescent tablet for orodispersible use Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
3 1mg budesonide effervescent tablet for orodispersible use Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
4 2mg budesonide effervescent tablet for orodispersible use Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
5 5 mg montelukast Montelukast 2件: D00529, D08229 💬 1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 1件: 98 💬
6 Ak002 - - - - 1件: 98 💬
7 Allergen - - - - 1件: 98 💬
8 Allergy immunotherapy (allergy shots) - - - - 1件: 98 💬
9 Antolimab - - - - 1件: 98 💬
10 Apt-1011 - - - - 1件: 98 💬
11 Apt-1011 - 3 mg - - - - 1件: 98 💬
12 Barium Barium - - - 2件: 19, 98 💬
13 Beclomethasone dipropionate Beclomethasone dipropionate 2件: D00689, D07495 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 97, 98 💬
14 Behavioral: six-foods elimination diet - - - - 1件: 98 💬
15 Benralizumab Benralizumab 1件: D09874 💬 1件: IL5RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 4件: 44, 45, 98, 162 💬
16 Bethanechol Bethanechol 1件: D01000 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件: 98 💬
17 Budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
18 Budesonide 0.5mg orodispersible tablet twice daily Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
19 Budesonide 1mg orodispersible tablet twice daily Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
20 Budesonide [0.4mg/ml] viscous suspension Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
21 Budesonide oral suspension Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
22 Budesonide oral suspension [0.2 mg/ml] Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
23 Budesonide plus prevacid Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
24 Buet 0.5 mg - - - - 1件: 98 💬
25 Buet 1mg - - - - 1件: 98 💬
26 Buet 2mg - - - - 1件: 98 💬
27 Buu 0.4mg/ml - - - - 1件: 98 💬
28 Caly-002 - - - - 1件: 98 💬
29 Cromolyn Cromoglicic acid 2件: D00526, D07753 💬 - - 3件:  2 , 85, 98 💬
30 Device: esophacap - - - - 1件: 98 💬
31 Device: intraluminal impedance - - - - 1件: 98 💬
32 Device: niox mino® airway inflammation monitor Methamidophos - - - 1件: 98 💬
33 Device: novel allergen-specific immune signature directed approach to dietary elimination therapy - - - - 1件: 98 💬
34 Dexlansoprazole Dexlansoprazole 1件: D08903 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 1件: 98 💬
35 Diagnostic test: barium esophagram Barium - - - 1件: 98 💬
36 Diagnostic test: bone mineral density (dexa) scan - - - - 1件: 98 💬
37 Diagnostic test: endoscopy while on study drug - - - - 1件: 98 💬
38 Diagnostic test: height measurement - - - - 1件: 98 💬
39 Diagnostic test: physical examination and questionnaires - - - - 1件: 98 💬
40 Diagnostic test: retrospective evaluation of endoscopy prior to study drug - - - - 1件: 98 💬
41 Diagnostic test: vitamin d measurement Vitamin D - - - 1件: 98 💬
42 Dupilumab Dupilumab 1件: D10354 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 4件: 51, 98, 160, 162 💬
43 Dupilumab (blinded) Dupilumab 1件: D10354 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 1件: 98 💬
44 Dupilumab (open-label) Dupilumab 1件: D10354 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 1件: 98 💬
45 Dupixent - - - - 3件: 98, 160, 162 💬
46 Eso-101 - - - - 1件: 98 💬
47 Esomeprazole Esomeprazole 4件: D01984, D04056, D07917, D09339 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 6件: 13, 46, 86, 98, 298, 299 💬
48 Eur-1100 - - - - 1件: 98 💬
49 Famotidine Famotidine 1件: D00318 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 4件:  6 , 46, 86, 98 💬
50 Florence 30 µg/ml - - - - 1件: 98 💬
51 Florence 60 µg/ml - - - - 1件: 98 💬
52 Florence 90 µg/ml - - - - 1件: 98 💬
53 Flovent - - - - 1件: 98 💬
54 Fluticasone Fluticasone 1件: D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 98, 228, 299 💬
55 Fluticasone mdi Fluticasone 1件: D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
56 Fluticasone propionate Fluticasone 2件: D01708, D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 98, 228 💬
57 Fluticasone propionate, 800 mcg twice daily (post 4fed failure) Fluticasone 2件: D01708, D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
58 Fluticasone propionate, 880 mcg twice daily (after 6fed failure) Fluticasone 2件: D01708, D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
59 Fluticasone propionate, usp Fluticasone 2件: D01708, D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
60 Gold Gold - - - 38件:  2 ,  5 ,  6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
61 High dose budesonide suspension Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
62 High dose budesonide tablet Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
63 Honey Honey 1件: D06776 💬 - - 3件: 57, 98, 299 💬
64 Infliximab Infliximab 1件: D02598 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬
65 Inhaled/swallowed budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
66 Intubated with propofol (ip) Propofol 1件: D00549 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件: 98 💬
67 Intubated with sevoflurane (is) Sevoflurane 1件: D00547 💬 - - 1件: 98 💬
68 Lansoprazole Lansoprazole 1件: D00355 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 7件: 63, 71, 85, 98, 166, 222, 299 💬
69 Lirentelimab - - - - 1件: 98 💬
70 Lirentelimab (ak002) - - - - 1件: 98 💬
71 Loratadine Loratadine 1件: D00364 💬 1件: HRH1 💬 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 3件: 13, 46, 98 💬
72 Losartan Losartan 2件: D00357, D08146 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
73 Losartan potassium Losartan 3件: D00357, D08146, D08403 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 5件: 36, 98, 167, 179, 215 💬
74 Low dose budesonide tablet Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
75 Medi-563 - - - - 3件: 44, 45, 98 💬
76 Mepolizumab Mepolizumab 1件: D04923 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 4件: 44, 45, 98, 162 💬
77 Mepolizumab 100 mg Mepolizumab 1件: D04923 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 1件: 98 💬
78 Mepolizumab 300 mg Mepolizumab 1件: D04923 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 1件: 98 💬
79 Milk Cow milk - - - 2件: 98, 210 💬
80 Mometasone Mometasone 3件: D00690, D03325, D08227 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 98, 162 💬
81 Mometasone furoate Mometasone 3件: D00690, D03325, D08227 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 98, 162 💬
82 Monitor Methamidophos - - - 18件:  2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬
83 Montelukast Montelukast 2件: D00529, D08229 💬 1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 5件: 13, 46, 85, 98, 228 💬
84 Montelukast/ singulair Montelukast 2件: D00529, D08229 💬 1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 1件: 98 💬
85 Nasonex - - - - 1件: 98 💬
86 Nitric oxide Nitric Oxide 1件: D00074 💬 - - 8件: 46, 85, 86, 98, 210, 251, 294, 299 💬
87 Oc000459 - - - - 1件: 98 💬
88 Omalizumab Omalizumab 1件: D05251 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 7件: 46, 53, 65, 98, 162, 226, 299 💬
89 Omeprazole Omeprazole 4件: D00455, D01207, D05259, D05261 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 16件:  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
90 Omeprazole 20mg bid Omeprazole 4件: D00455, D01207, D05259, D05261 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 1件: 98 💬
91 Oral budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
92 Oral budesonide suspension (mb-9) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
93 Oral budesonide suspension (obs) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
94 Oral cromolyn sodium Cromoglicic acid 2件: D00526, D07753 💬 - - 1件: 98 💬
95 Oral viscous budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
96 Oral viscous budesonide (ovb) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
97 Other: 1 food elimination diet - - - - 1件: 98 💬
98 Other: 1 food elimination diet therapy - - - - 1件: 98 💬
99 Other: 4 food elimination diet - - - - 1件: 98 💬
100 Other: 4 food elimination diet (post 1fed failure) - - - - 1件: 98 💬
101 Other: 6 food elimination diet (after 1fed failure) - - - - 1件: 98 💬
102 Other: 6 food elimination diet therapy - - - - 1件: 98 💬
103 Other: antigen (wheat base soy sauce) spray Wheat 1件: D06902 💬 - - 1件: 98 💬
104 Other: assessment of medication compliance - - - - 1件: 98 💬
105 Other: d-xylose Xylose 1件: D06346 💬 - - 1件: 98 💬
106 Other: elimination diet - - - - 1件: 98 💬
107 Other: honey Honey 1件: D06776 💬 - - 1件: 98 💬
108 Other: medication compliance phone call - - - - 1件: 98 💬
109 Other: oral nitric oxide testing Nitric Oxide 1件: D00074 💬 - - 1件: 98 💬
110 Other: saline - - - - 8件:  2 ,  6 , 46, 97, 98, 256, 274, 301 💬
111 Other: symptom survey - - - - 1件: 98 💬
112 Other: xanthan gum Xanthan gum 1件: D06333 💬 - - 1件: 98 💬
113 Potassium Potassium 1件: D08403 💬 - - 10件: 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬
114 Procedure: esophageal dilation - - - - 1件: 98 💬
115 Procedure: esophagogastroduodenoscopy - - - - 1件: 98 💬
116 Procedure: intraluminal impedance - - - - 1件: 98 💬
117 Propofol Propofol 1件: D00549 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 8件:  6 , 21, 22, 34, 46, 84, 98, 296 💬
118 Qax576 - - - - 4件: 51, 85, 96, 98 💬
119 Radiation: computerized tomography scan - - - - 1件: 98 💬
120 Radiation: esophageal barium xray Barium - - - 1件: 98 💬
121 Radiation: planar images - - - - 1件: 98 💬
122 Radiation: single photon emission computed tomography scans - - - - 1件: 98 💬
123 Reslizumab Reslizumab 1件: D08985 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 2件: 44, 98 💬
124 Rpc4046 - - - - 1件: 98 💬
125 Sb-240563 - - - - 3件: 44, 45, 98 💬
126 Sch55700 - - - - 1件: 98 💬
127 Sevoflurane Sevoflurane 1件: D00547 💬 - - 6件:  6 , 21, 22, 34, 98, 296 💬
128 Sirolimus Sirolimus 1件: D00753 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 35件:  6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬
129 Steroid and proton pump inhibitor therapy - - - - 1件: 98 💬
130 Sucralfate Sucralfate 1件: D00446 💬 - - 1件: 98 💬
131 Swallowed fluticasone Fluticasone 1件: D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
132 Technetium tc 99m Technetium Tc-99m - - - 2件: 46, 98 💬
133 Treat with lansoprazole 30 mg bid for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms Lansoprazole 1件: D00355 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 1件: 98 💬
134 Viaskin milk 500 mcg Cow milk - - - 1件: 98 💬
135 Viscous/swallowed budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
136 Vitamin d Vitamin D - - - 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬
137 Vonoprazan Vonoprazan 1件: D11784 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 2件: 63, 98 💬
138 Wheat Wheat 1件: D06902 💬 - - 2件: 98, 266 💬
139 Xanthan gum Xanthan gum 1件: D06333 💬 - - 1件: 98 💬
140 Xylose Xylose 1件: D06346 💬 - - 1件: 98 💬
141 Zofran - no intubation - - - - 1件: 98 💬

先頭へ